查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945318

2026年全球荷爾蒙子宮內避孕器（IUD）市場報告

Hormonal Intrauterine Devices (IUDs) Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，含激素子宮內避孕器（IUD）市場發展迅速，預計將從2025年的28.7億美元成長到2026年的31.8億美元，複合年成長率達10.6%。這一成長可歸因於人們對計劃生育選擇的認知不斷提高、女性生殖健康項目的擴展、對長期避孕方式的偏好日益成長、含激素節育器的普及以及公共衛生舉措的支持。

預計未來幾年，含激素子宮內避孕器（IUD）市場將快速成長，到2030年市場規模將達到47.4億美元，複合年成長率（CAGR）為10.5%。預測期內的成長要素包括：非手術避孕需求不斷成長、對月經健康管理的關注度日益提高、新興市場准入範圍擴大、對女性健康技術的投資增加以及激素輸送系統的不斷創新。預測期內的主要趨勢包括：低劑量含激素子宮內避孕器的使用率不斷提高、對長效可逆避孕方法（LARC）的需求不斷成長、對無框架避孕器的偏好日益增強、治療性子宮內避孕器的應用範圍擴大以及對患者舒適度和安全性的日益重視。

預計未來幾年，意外懷孕的增加將推動含激素子宮內避孕器（IUD）市場的成長。意外懷孕是指在受孕時沒有計劃或意願的懷孕。原因多種多樣，包括避孕失敗、避孕措施匱乏、避孕措施濫用、性侵犯。有效避孕措施的匱乏限制了個人的生育選擇，從而增加了意外懷孕的可能性。含激素子宮內避孕器在預防懷孕方面非常有效，失敗率低於1%。根據類型不同，它們可提供三至七年的長期保護，是希望避免意外懷孕人士的可靠選擇。例如，據總部位於美國的專業組織「家庭計畫協會」稱，美國墮胎數量從2023年的105萬例增加到2024年的114萬例。因此，意外懷孕的增加推動了對含激素子宮內避孕器的需求。

荷爾蒙子宮內避孕器市場的主要企業致力於開發先進的解決方案，例如levonorgestrel子宮內避孕器（IUD），它有助於減少月經出血和月經經痛。levonorgestrel子宮內避孕器是一種長效避孕裝置，放置於子宮內。它透過逐漸釋放levonorgestrel來預防懷孕。例如，2024年10月，總部位於美國的非營利組織Medicines360在尚比亞推出了52毫克levonorgestrel子宮內避孕器「Avibela」。本產品具有雙重功效：長達八年的避孕效果和長達五年的緩解月經過多。其避孕作用是透過增稠子宮頸黏液，阻止精子進入子宮來實現的；而其治療作用則是透過使子宮內膜變薄來減少月經量。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球荷爾蒙子宮內避孕器（IUD）市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 永續性、氣候技術和循環經濟
    • 人工智慧（AI）和自主人工智慧
  • 主要趨勢
    • 低劑量荷爾蒙子宮內避孕器使用率不斷提高
    • 對長效可逆避孕法的需求不斷成長
    • 人們越來越喜歡無邊框設備
    • 擴大治療性子宮內避孕器的適應症
    • 更重視患者的舒適度與安全性

第5章 終端用戶產業市場分析

  • 醫院
  • 婦科診所
  • 計劃生育診所
  • 生殖健康中心
  • 門診治療中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球荷爾蒙子宮內避孕器（IUD）市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球荷爾蒙子宮內避孕器（IUD）市場規模、對比及成長率分析
  • 全球荷爾蒙子宮內避孕器（IUD）市場表現：規模與成長，2020-2025年
  • 全球荷爾蒙子宮內避孕器（IUD）市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 13毫克激素子宮內避孕器、19毫克激素子宮內避孕器、52毫克激素子宮內避孕器
  • 透過設備設計
  • 有框架子宮內避孕器，無框架子宮內避孕器
  • 依激素類型
  • levonorgestrel子宮內避孕器，黃體素子宮內避孕器
  • 透過使用
  • 年齡範圍：20-24歲、25-34歲、35-44歲等用途
  • 按類型細分：13毫克激素子宮內避孕器
  • 低劑量 13 毫克子宮內避孕器，特殊用途 13 毫克子宮內避孕器
  • 按類型細分：19毫克激素子宮內避孕器
  • 低劑量 19 毫克子宮內避孕器，特殊用途 19 毫克子宮內避孕器
  • 按類型細分：52毫克激素子宮內避孕器
  • 標準型 52 毫克子宮內避孕器、緩釋型 52 毫克子宮內避孕器以及用於治療月經過多或子宮內膜異位症的特殊型 52 毫克子宮內避孕器

第10章 區域與國家分析

  • 全球荷爾蒙子宮內避孕器（IUD）市場：區域分析、預測與展望（2020-2025年、2025-2030年、2035年）。
  • 全球荷爾蒙子宮內避孕器（IUD）市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 荷爾蒙子宮內避孕器（IUD）市場：競爭格局與市場佔有率，2024年
  • 荷爾蒙子宮內避孕器（IUD）市場：公司估值矩陣
  • 荷爾蒙子宮內避孕器（IUD）市場：公司概況
    • Bayer AG
    • Organon & Companies
    • Gedeon Richter Plc
    • Meril Life Science Pvt Ltd.
    • Teva UK Limited

第37章：其他領先和創新企業

  • Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年荷爾蒙子宮內避孕器（IUD）市場：提供新機會的國家
  • 2030年荷爾蒙子宮內避孕器（IUD）市場：充滿新機會的細分市場
  • 2030年荷爾蒙子宮內避孕器（IUD）市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MHIDI01_G26Q1

Hormonal intrauterine devices (IUDs) are small, T-shaped plastic devices that are inserted into the uterus and release progestin, a synthetic hormone. These devices prevent pregnancy by thickening cervical mucus to block sperm, thinning the uterine lining to impede implantation, and sometimes suppressing ovulation. Additionally, they can reduce menstrual bleeding and cramping, and in some cases, may stop periods altogether.

The primary types of hormonal IUDs include 13-milligram, 19-milligram, and 52-milligram hormonal IUDs. The 13-milligram hormonal IUDs, which release a low dose of hormones for up to three years, are becoming increasingly popular among women seeking long-acting contraceptive options with lower hormone exposure. The design of these devices varies, including framed and frameless IUDs, and they feature different hormone types such as levonorgestrel-releasing and progesterone-releasing IUDs. These options cater to various age groups, including those aged 20-24, 25-34, and 35-44, among other applications.

Tariffs are impacting the hormonal intrauterine devices market by increasing costs of imported medical-grade polymers, hormone compounds, packaging materials, and precision manufacturing equipment. Healthcare providers in North America and Europe are most affected due to reliance on imported device components, while Asia-Pacific faces pricing pressure on export-oriented production. These tariffs are contributing to higher device procurement costs and slower market penetration in cost-sensitive regions. However, they are also encouraging localized manufacturing, regional supply chain development, and domestic production of hormonal IUDs.

The hormonal intrauterine devices (iuds) market research report is one of a series of new reports from The Business Research Company that provides hormonal intrauterine devices (iuds) market statistics, including hormonal intrauterine devices (iuds) industry global market size, regional shares, competitors with a hormonal intrauterine devices (iuds) market share, detailed hormonal intrauterine devices (iuds) market segments, market trends and opportunities, and any further data you may need to thrive in the hormonal intrauterine devices (iuds) industry. This hormonal intrauterine devices (iuds) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hormonal intrauterine devices (iuds) market size has grown rapidly in recent years. It will grow from $2.87 billion in 2025 to $3.18 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing awareness of family planning options, expansion of women's reproductive healthcare programs, rising preference for long-term contraception, availability of hormone-based devices, support from public health initiatives.

The hormonal intrauterine devices (iuds) market size is expected to see rapid growth in the next few years. It will grow to $4.74 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing demand for non-surgical contraceptive solutions, rising focus on menstrual health management, expansion of access in emerging markets, growing investments in women's health technologies, increasing innovation in hormone delivery systems. Major trends in the forecast period include increasing adoption of low-dose hormonal iuds, rising demand for long-acting reversible contraceptives, growing preference for frameless device designs, expansion of therapeutic iud applications, enhanced focus on patient comfort and safety.

The rise in unwanted pregnancies is expected to drive the growth of the hormonal intrauterine devices (IUDs) market in the coming years. Unwanted pregnancies are those that occur without planning or desire at the time of conception. They can result from various factors, including contraceptive failure, limited access to birth control, incorrect use of contraception, or sexual violence. Restricted access to effective contraception increases the likelihood of unwanted pregnancies by limiting individuals' control over their reproductive choices. Hormonal IUDs are highly effective in preventing pregnancy, with a failure rate below 1%. They offer long-term protection, ranging from three to seven years depending on the type, making them a dependable option for individuals seeking to avoid unwanted pregnancies. For example, according to the Society for Family Planning, a US-based professional organization, abortions in the United States rose to 1.14 million in 2024, up from 1.05 million in 2023. Consequently, the increase in unwanted pregnancies is propelling the demand for hormonal IUDs.

Major companies in the hormonal intrauterine devices market are focusing on developing advanced solutions, such as levonorgestrel IUDs, which help reduce menstrual bleeding and cramps. Levonorgestrel IUDs are long-term contraceptive devices inserted into the uterus that gradually release the hormone levonorgestrel to prevent pregnancy. For instance, in October 2024, Medicines360, a US-based nonprofit organization, launched Avibela, a 52 mg levonorgestrel IUD, in Zambia. It provides dual benefits: up to eight years of pregnancy prevention and up to five years of relief from heavy menstrual bleeding. Its contraceptive effect is achieved by thickening cervical mucus to block sperm from reaching the uterus, while its therapeutic effect reduces menstrual flow by thinning the uterine lining.

In January 2024, Medicines360 partnered with DKT WomanCare Global to expand the accessibility of the affordable hormonal IUD Avibela. This collaboration aimed to increase awareness and reach, particularly in underserved regions, improving global sexual and reproductive health. DKT WomanCare Global, a France-based organization, focuses on enhancing the availability, accessibility, and affordability of sexual and reproductive health products for women.

Major companies operating in the hormonal intrauterine devices (iuds) market are Bayer AG, Organon & Companies, Gedeon Richter Plc, Meril Life Science Pvt Ltd., Teva UK Limited, Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

North America was the largest region in the hormonal intrauterine devices (IUDs) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hormonal intrauterine devices (iuds) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hormonal intrauterine devices (iuds) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hormonal intrauterine devices (IUDs) market consists of sales of hormone reservoir, strings, and insertion or removal instruments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hormonal Intrauterine Devices (IUDs) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses hormonal intrauterine devices (iuds) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hormonal intrauterine devices (iuds) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hormonal intrauterine devices (iuds) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: 13 Milligram Hormonal Intrauterine Devices; 19 Milligram Hormonal Intrauterine Devices; 52 Milligram Hormonal Intrauterine Devices
  • 2) By Device Design: Framed Intrauterine Devices; Frameless Intrauterine Devices
  • 3) By Hormone Type: Levonorgestrel Releasing Intrauterine Devices; Progesterone Releasing Intrauterine Devices
  • 4) By Application: Age 20-24; Age 25-34; Age 35-44; Other Applications
  • Subsegments:
  • 1) By 13 Milligram Hormonal Intrauterine Devices: Low-Dose 13 Mg IUDs; Specialty 13 Mg IUDs For Specific Conditions
  • 2) By 19 Milligram Hormonal Intrauterine Devices: Low-Dose 19 Mg IUDs; Specialty 19 Mg IUDs For Specific Conditions
  • 3) By 52 Milligram Hormonal Intrauterine Devices: Standard 52 Mg IUDs; Extended-Release 52 Mg IUDs; Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis
  • Companies Mentioned: Bayer AG; Organon & Companies; Gedeon Richter Plc; Meril Life Science Pvt Ltd.; Teva UK Limited; Medicines360; HLL Lifecare Limited; Pregna International Ltd.; DKT WomanCare Global; SMB Corporation of India; Oy Leiras; OCON Healthcare; Bayer Healthcare Pharmaceuticals; CooperSurgical Inc.; Mithra Pharmaceuticals; Shanghai Dahua Medical Apparatus Co. Ltd.; Beijing Zizhu Pharmaceutical Co. Ltd.; Shanghai Jiansheng Medical Devices Co. Ltd.; Zhejiang Xianju Pharmaceutical Co. Ltd.; Shanghai Chuangling Medical Devices Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Hormonal Intrauterine Devices (IUDs) Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Hormonal Intrauterine Devices (IUDs) Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Hormonal Intrauterine Devices (IUDs) Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Hormonal Intrauterine Devices (IUDs) Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Low-Dose Hormonal Iuds
    • 4.2.2 Rising Demand For Long-Acting Reversible Contraceptives
    • 4.2.3 Growing Preference For Frameless Device Designs
    • 4.2.4 Expansion Of Therapeutic Iud Applications
    • 4.2.5 Enhanced Focus On Patient Comfort And Safety

5. Hormonal Intrauterine Devices (IUDs) Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Gynecology Clinics
  • 5.3 Family Planning Clinics
  • 5.4 Reproductive Health Centers
  • 5.5 Ambulatory Care Centers

6. Hormonal Intrauterine Devices (IUDs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hormonal Intrauterine Devices (IUDs) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Hormonal Intrauterine Devices (IUDs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Hormonal Intrauterine Devices (IUDs) Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Hormonal Intrauterine Devices (IUDs) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Hormonal Intrauterine Devices (IUDs) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hormonal Intrauterine Devices (IUDs) Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hormonal Intrauterine Devices (IUDs) Market Segmentation

  • 9.1. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 13 Milligram Hormonal Intrauterine Devices, 19 Milligram Hormonal Intrauterine Devices, 52 Milligram Hormonal Intrauterine Devices
  • 9.2. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Device Design, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Framed Intrauterine Devices, Frameless Intrauterine Devices
  • 9.3. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Levonorgestrel Releasing Intrauterine Devices, Progesterone Releasing Intrauterine Devices
  • 9.4. Global Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Age 20-24, Age 25-34, Age 35-44, Other Applications
  • 9.5. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 13 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Low-Dose 13 Mg IUDs, Specialty 13 Mg IUDs For Specific Conditions
  • 9.6. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 19 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Low-Dose 19 Mg IUDs, Specialty 19 Mg IUDs For Specific Conditions
  • 9.7. Global Hormonal Intrauterine Devices (IUDs) Market, Sub-Segmentation Of 52 Milligram Hormonal Intrauterine Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standard 52 Mg IUDs, Extended-Release 52 Mg IUDs, Specialty 52 Mg IUDs For Heavy Menstrual Bleeding Or Endometriosis

10. Hormonal Intrauterine Devices (IUDs) Market Regional And Country Analysis

  • 10.1. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Hormonal Intrauterine Devices (IUDs) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market

  • 11.1. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hormonal Intrauterine Devices (IUDs) Market

  • 12.1. China Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hormonal Intrauterine Devices (IUDs) Market

  • 13.1. India Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hormonal Intrauterine Devices (IUDs) Market

  • 14.1. Japan Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hormonal Intrauterine Devices (IUDs) Market

  • 15.1. Australia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hormonal Intrauterine Devices (IUDs) Market

  • 16.1. Indonesia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hormonal Intrauterine Devices (IUDs) Market

  • 17.1. South Korea Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hormonal Intrauterine Devices (IUDs) Market

  • 18.1. Taiwan Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hormonal Intrauterine Devices (IUDs) Market

  • 19.1. South East Asia Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hormonal Intrauterine Devices (IUDs) Market

  • 20.1. Western Europe Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hormonal Intrauterine Devices (IUDs) Market

  • 21.1. UK Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hormonal Intrauterine Devices (IUDs) Market

  • 22.1. Germany Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hormonal Intrauterine Devices (IUDs) Market

  • 23.1. France Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hormonal Intrauterine Devices (IUDs) Market

  • 24.1. Italy Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hormonal Intrauterine Devices (IUDs) Market

  • 25.1. Spain Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market

  • 26.1. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hormonal Intrauterine Devices (IUDs) Market

  • 27.1. Russia Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hormonal Intrauterine Devices (IUDs) Market

  • 28.1. North America Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hormonal Intrauterine Devices (IUDs) Market

  • 29.1. USA Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hormonal Intrauterine Devices (IUDs) Market

  • 30.1. Canada Hormonal Intrauterine Devices (IUDs) Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hormonal Intrauterine Devices (IUDs) Market

  • 31.1. South America Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hormonal Intrauterine Devices (IUDs) Market

  • 32.1. Brazil Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hormonal Intrauterine Devices (IUDs) Market

  • 33.1. Middle East Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hormonal Intrauterine Devices (IUDs) Market

  • 34.1. Africa Hormonal Intrauterine Devices (IUDs) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Hormonal Intrauterine Devices (IUDs) Market, Segmentation By Type, Segmentation By Device Design, Segmentation By Hormone Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hormonal Intrauterine Devices (IUDs) Market Regulatory and Investment Landscape

36. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape And Company Profiles

  • 36.1. Hormonal Intrauterine Devices (IUDs) Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Hormonal Intrauterine Devices (IUDs) Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Hormonal Intrauterine Devices (IUDs) Market Company Profiles
    • 36.3.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Organon & Companies Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Gedeon Richter Plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Meril Life Science Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Teva UK Limited Overview, Products and Services, Strategy and Financial Analysis

37. Hormonal Intrauterine Devices (IUDs) Market Other Major And Innovative Companies

  • Medicines360, HLL Lifecare Limited, Pregna International Ltd., DKT WomanCare Global, SMB Corporation of India, Oy Leiras, OCON Healthcare, Bayer Healthcare Pharmaceuticals, CooperSurgical Inc., Mithra Pharmaceuticals, Shanghai Dahua Medical Apparatus Co. Ltd., Beijing Zizhu Pharmaceutical Co. Ltd., Shanghai Jiansheng Medical Devices Co. Ltd., Zhejiang Xianju Pharmaceutical Co. Ltd., Shanghai Chuangling Medical Devices Co. Ltd.

38. Global Hormonal Intrauterine Devices (IUDs) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hormonal Intrauterine Devices (IUDs) Market

40. Hormonal Intrauterine Devices (IUDs) Market High Potential Countries, Segments and Strategies

  • 40.1 Hormonal Intrauterine Devices (IUDs) Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Hormonal Intrauterine Devices (IUDs) Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Hormonal Intrauterine Devices (IUDs) Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer